Evidence map›Paper›PMID 19747576›Full record

ArticleVaccine2009

Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants.

U Malhotra, J Nolin, H Horton, F Li, L Corey, J I Mullins, M J McElrath

Abstract read
In one paragraph

Article in Vaccine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

U MalhotraFred Hutchinson Cancer Research Center, Seattle, WA, USA. uma.malhotra@vmmc.org
J Nolin
H Horton
F Li
L Corey
J I Mullins
M J McElrath
University of Washington · USFred Hutch Cancer Center · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Viral Determinants of HIV-1 Transmission in African HeterosexualsP01AI057005 · NIAID · UNIVERSITY OF WASHINGTON · PI COREY, LAWRENCE · 2003 to 2014
$20.5M
HIV-1 Diversity in Vaccine Evaluation and DesignR21AI064061 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MALHOTRA, UMA · 2005 to 2006
$511k
NIAID NIH HHS AI27757NIAID NIH HHS AI57005NIAID NIH HHS AI64061NIAID NIH HHS P01 AI057005NIAID NIH HHS P30 AI027757NIAID NIH HHS R21 AI064061
6 · The paper itself

Abstract

To understand how broad recognition of HIV-1 variants may be achieved we examined T-cell reactivity in newly infected persons as well as vaccine recipients to a broad spectrum of potential T-cell epitope (PTE) variants containing conservative, semi-conservative and non-conservative amino acid substitutions. Among early infected persons T-cells recognized epitope variants with one substitution at a significantly higher frequency versus those with two (P=0.0098) and three (P=0.0125) substitutions. Furthermore T-cells recognized variants containing conservative substitutions at a higher frequency versus those containing semi-conservative (P=0.0029) and non-conservative (P<0.0001) substitutions. Similar effects were observed on recognition of variants by vaccine-induced T-cells. Moreover even when variants were recognized, the IFN-gamma and granzyme B responses as well as T-cell proliferation were of lower magnitude. Finally, we show that epitope distribution is strongly influenced by both processing preferences and amino acid entropy. We conclude that induction of broad immunity is likely to require immunogen sequences that encompass multiple variants. However, cost-effective design of peptide and sequence based vaccine immunogens that provide maximal coverage of circulating sequences may be achieved through emphasis on virus domains likely to be T-cell targets.

Indexed as

AdultAmino Acid SubstitutionDNA, ViralEpitopes, T-LymphocyteGranzymesHIV-1HIV AntigensHIV InfectionsHumansInterferon-gammaMaleMiddle Agednef Gene Products, Human Immunodeficiency VirusSequence Analysis, ProteinT-LymphocytesYoung AdultDNA, ViralEpitopes, T-LymphocyteGranzymesHIV AntigensInterferon-gammanef Gene Products, Human Immunodeficiency Virus

Identifiers

PMID19747576
PMCPMC2845637
OpenAlexW2003363998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.